The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries

SIMPLE SUMMARY: To capitalize on the revolutionary anticancer efficacy of immune checkpoint inhibitors (ICPi) in an expanding list of tumors, including hematological malignancies, it is mandatory to mitigate the immune-related (ir) adverse events, among which prevail the ir thyroid disorders. Curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Deligiorgi, Maria V., Sagredou, Sofia, Vakkas, Lampros, Trafalis, Dimitrios T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582503/
https://www.ncbi.nlm.nih.gov/pubmed/34771441
http://dx.doi.org/10.3390/cancers13215277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582503/
https://www.ncbi.nlm.nih.gov/pubmed/34771441
http://dx.doi.org/10.3390/cancers13215277

Ejemplares similares